-
Mashup Score: 3Incidence Rates and Case-Fatality Rates of Cerebral Vein Thrombosis: A Population-Based Study - 3 year(s) ago
Background and Purpose: Cerebral vein thrombosis (CVT) incidence is estimated to be >10 per 1 000 000 per year. Few population-based studies investigating case-fatality rates (CFRs) and pyogenic/nonp
Source: StrokeCategories: Latest Headlines, NeurologyTweet
-
Mashup Score: 15
A new series of cases of cerebral venous sinus thrombosis (CVST) linked to the adenoviral vector COVID-19 vaccines has been reported, confirming the severity of the reaction and the associated high mortality.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
🆕 series of cases of #CVST linked to the adenoviral vector COVID-19 vaccines has been reported, confirming the severity of the reaction and the associated high mortality. https://t.co/kXh1sSVgwP https://t.co/S1U0frvl5i
-
-
Mashup Score: 2
A new series of cases of cerebral venous sinus thrombosis (CVST) linked to the adenoviral vector COVID-19 vaccines has been reported, confirming the severity of the reaction and the associated high mortality.
Source: MedscapeCategories: Latest Headlines, NeurologyTweet-
A 🆕 series of cases of #CVST linked to the adenoviral vector COVID-19 vaccines has been reported, confirming the severity of the reaction and the associated high mortality. https://t.co/vnYGkvOgar https://t.co/MCXQR0E65T
-
-
Mashup Score: 13
A new series of cases of cerebral venous sinus thrombosis (CVST) linked to the adenoviral vector COVID-19 vaccines has been reported, confirming the severity of the reaction and the associated high mortality.
Source: MedscapeCategories: Cardiology News and Journals, Latest HeadlinesTweet-
A new series of cases of #CVST linked to the adenoviral vector COVID-19 vaccines has been reported, confirming the severity of the reaction and the associated high mortality. https://t.co/9BtzjKKPN8 https://t.co/NRMXe79C87
-
-
Mashup Score: 2
CVST represents ~ 1% of strokes. It most commonly affect young individuals with transient (pregnancy, use of oral contraceptives) or permanent (thrombophilia) predisposing conditions. Several studies showed a delay in the diagnosis and treatment, a common cause of neurological deterioration that results in poor clinical outcomes. This webinar will offer a comprehensive approach to increase…
Source: Zoom Video CommunicationsCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Register today for a State-of-the-Art #webinar on Diagnosis and Management of #CVST Sept 29, 2021 4PM CET/GMT +1 @gsaposnik @Jonatha88386639 @VancouverStroke @RIHospital @WorldStrokeEd @American_Heart @American_Stroke #stroke https://t.co/zOrkzPutO7 https://t.co/SbaAJNvqmM
-
-
Mashup Score: 2
CVST represents ~ 1% of strokes. It most commonly affect young individuals with transient (pregnancy, use of oral contraceptives) or permanent (thrombophilia) predisposing conditions. Several studies showed a delay in the diagnosis and treatment, a common cause of neurological deterioration that results in poor clinical outcomes. This webinar will offer a comprehensive approach to increase…
Source: Zoom Video CommunicationsCategories: Cardiology News and Journals, Latest HeadlinesTweet-
Register today for a State-of-the-Art #webinar on Diagnosis and Management of #CVST Sept 29, 2021 4PM CET/GMT +1 @gsaposnik @Jonatha88386639 @VancouverStroke @RIHospital @WorldStrokeEd @American_Heart @American_Stroke #stroke https://t.co/zOrkzPutO7 https://t.co/TszE9EWti7
-
-
Mashup Score: 0
Another study has suggested that rates of cerebral venous sinus thrombosis (CVST) are much higher among patients with COVID-19 than after vaccination with either the AstraZeneca or J&J vaccines.
Source: MedscapeCategories: General Medicine News, Latest HeadlinesTweet-
Rates of #CVST are much higher among people with COVID-19 than those vaccinated with either the AstraZeneca or the Johnson & Johnson shots. https://t.co/o6gnBBrE3g
-
-
Mashup Score: 4Management of CVST With Vaccine-Induced Thrombocytopenia - American College of Cardiology - 3 year(s) ago
Geoffrey D. Barnes, MD, MSc, FACC
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
The following are 🔑 points to remember from an article on the diagnosis and management of cerebral venous sinus #thrombosis with vaccine-induced thrombotic #thrombocytopenia: https://t.co/l5oEf4uFBC @GBarnesMD #CVST #COVIDVaccine
-
-
Mashup Score: 5Cerebral Venous Sinus Thrombosis With Thrombocytopenia After J&J Vaccine - American College of Cardiology - 3 year(s) ago
Geoffrey D. Barnes, MD, MSc, FACC
Source: American College of CardiologyCategories: Cardiology News and Journals, Latest HeadlinesTweet-
How did patients present with cerebral venous sinus thrombosis and #thrombocytopenia following receipt of the Ad26.COV2.S #COVID19 vaccine (Janssen/Johnson & Johnson)? Find out here: https://t.co/qHniibtmTD #JNJ #CVST @GBarnesMD https://t.co/H6DZAUSvya
-
-
Mashup Score: 0
On Friday, the Advisory Committee on Immunization Practices voted to recommend resuming the use of the one-shot Johnson & Johnson COVID-19 vaccine in Americans aged 18 years and older.They said the benefits of the vaccine outweigh the risks for blood clots associated with its use.
Source: www.healio.comCategories: General Medicine News, Latest HeadlinesTweet-
@CDCgov Advisory Committee on Immunization Practices voted in favor of the use of the #Johnson&Johnson #COVID19 vaccine among persons aged 18 and older following cases of #CVST with thrombocytopenia in the first 6.8 million doses. @InfectDisNews https://t.co/0q7lcZp9Jd
-
Large, Italian, epidemiologic study finds a Cerebral Venous Sinus Thrombosis incidence rate of 11.6 per 1,000,000 and an in-hospital mortality rate of 3%. #STROKE #CVST https://t.co/S2H8ADAUcQ @aldobonaventura @Avecchie https://t.co/T6KZqO1N9S